​CHI coordinates research across Stevens' four schools and in collaboration with external partners including leading hospitals, health care centers and government agencies. We also operate a Drug Discovery & Biotechnology Lab within the Center. Here are a few examples of our leading-edge research.

Device Grows 3D Tissues

Microfluidic devices create a realistic environment for customizing more effective drug treatments.

Stevens faculty members Woo Lee, Hongjun Wang and Joung-Hyun Lee are coordinating a multi-disciplinary effort to develop and fully explore the potential of novel microfluidic device systems that promise an entirely new tissue culture protocol that may one day replace the traditional petri dish in labs worldwide.

Safer Orthopedic Implants
Cutting-edge biomaterials make implant surfaces resist bacteria to increase patient outcomes.

Professor Matthew Libera introduces innovative hydrogel-treated surfaces, ones which may dramatically reduce the risk of infection that often occurs during orthopedic implant procedures.

Collaborating across disciplines with Dr. Libera, Biomedical Engineering undergraduate Aidan Zerdoum describes using a Focused Ion Beam to determine what antibacterial treatment is most effective in a biofilm.

Creating Skin Grafts for Burn Victims

Stevens professor Hongjun Wang and Ph.D. candidate Babak Mahjour explain how they use tissue engineering to create skin grafts for burn victims.

Inkjet Printer Develops Antibiotics
Infection-resistant orthopedic implants combat biofilms.

Despite the tremendous improvements in orthopedic implant procedures, hospital-acquired bacterial infection is the dominant cause of implant failure and causes significant patient trauma, as well as a healthcare burden of $3 billion annually to the U.S. economy each year. Stevens' infection-resistant orthopedic research explores the inkjet printing of drug-eluting, bioresorbable micropatterns onto the surface of orthopedic implants as a novel means of preventing biofilm formation on and bacterial infection of implants.

Progeria Protein Discovery
New characteristics linked to premature aging disease.

Stevens professor Joseph Glavy studies the smallest and most basic elements of life. His team has uncovered a disease-related protein outside of its known range and published the results in Cell Cycle.

Can an Ant Colony Help Trauma Patients?
Swarm intelligence, as seen in an ant colony, allows biomedical engineers to more accurately predict tissue growth in nerve grafts.

The National Institutes of Health (NIH) has recently awarded a grant to researchers to pursue novel approaches to engineering peripheral nerve tissues that incorporate lessons from swarm intelligence into computer simulations. Dr. Xiaojun Yu, an associate professor of Biomedical Engineering, and Yan Meng, an assistant professor of computer engineering, are collaborating to break through the existing technology barrier and develop smarter nerve tissue grafts.

Nanofibers Grow Better Bones
Growing load-bearing human bone tissues with nanotechnology to help speed recovery of America's 6.2 million annual bone fractures.

Funded by the National Science Foundation, Hongjun Wang, a professor in the Department of Biomedical Engineering, and his collaborators have developed a revolutionary bottom-up approach for reconstructing intricate bone tissue with the potential to form hierarchical cortical bone.

Accelerating Pharmaceuticals into the Market

Computational chemistry allows scientists to test drugs virtually before running expensive trials.

Dr. Sid Topiol and his Stevens team hunt for the next great therapies and medications by harnessing the power of computing to simulate drug interactions before they are tested on patients.

Center for Healthcare Innovation logo

Funding & Collaborators

National Institutes of Health (NIH)

National Science Foundation (NSF)

Merck

Roche

Pfizer

Hackensack University Medical Center

Columbia University

Seton Hall University

Georgetown University